
Over the last 7 days, the Healthcare Services industry has dropped 2.3%, driven by pullbacks in Excelsior Medical and Universal Vision Biotechnology of 2.9% and 3.1%, respectively. Meanwhile, Sofiva GenomicsLtd actually outperformed within the industry, gaining 16% in the last week. The industry has fallen 17% in the last year. As for the next few years, earnings are expected to grow by 32% per annum.
Has the Taiwanese Healthcare Services Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Sun, 08 Feb 2026 | NT$70.8b | NT$41.6b | NT$2.9b | 17.2x | 24.8x | 1.7x |
| Tue, 06 Jan 2026 | NT$73.9b | NT$41.6b | NT$2.9b | 17.2x | 25.9x | 1.8x |
| Thu, 04 Dec 2025 | NT$75.3b | NT$41.6b | NT$2.9b | 17.5x | 26.4x | 1.8x |
| Sat, 01 Nov 2025 | NT$73.4b | NT$41.7b | NT$2.8b | 19.2x | 26.2x | 1.8x |
| Mon, 29 Sep 2025 | NT$74.6b | NT$41.7b | NT$2.8b | 18.9x | 26.6x | 1.8x |
| Wed, 27 Aug 2025 | NT$75.3b | NT$41.9b | NT$2.8b | 18.5x | 26.6x | 1.8x |
| Fri, 25 Jul 2025 | NT$76.1b | NT$41.3b | NT$3.1b | 17.8x | 24.6x | 1.8x |
| Sun, 22 Jun 2025 | NT$74.2b | NT$41.3b | NT$3.1b | 18.4x | 24x | 1.8x |
| Tue, 20 May 2025 | NT$75.3b | NT$41.3b | NT$3.1b | 18.2x | 24.4x | 1.8x |
| Thu, 17 Apr 2025 | NT$78.4b | NT$41.2b | NT$2.7b | 18.4x | 29.4x | 1.9x |
| Sat, 15 Mar 2025 | NT$86.6b | NT$40.9b | NT$2.6b | 19.3x | 33.9x | 2.1x |
| Mon, 10 Feb 2025 | NT$87.8b | NT$41.2b | NT$2.7b | 20.8x | 32.6x | 2.1x |
| Wed, 08 Jan 2025 | NT$86.1b | NT$39.9b | NT$2.9b | 20.2x | 30x | 2.2x |
| Fri, 06 Dec 2024 | NT$89.9b | NT$39.9b | NT$2.9b | 19.6x | 31.4x | 2.3x |
| Sun, 03 Nov 2024 | NT$81.7b | NT$39.4b | NT$2.8b | 22.6x | 29.1x | 2.1x |
| Tue, 01 Oct 2024 | NT$86.9b | NT$39.4b | NT$2.8b | 23.2x | 30.9x | 2.2x |
| Thu, 29 Aug 2024 | NT$84.5b | NT$39.6b | NT$2.8b | 23.3x | 30x | 2.1x |
| Sat, 27 Jul 2024 | NT$86.7b | NT$38.9b | NT$2.8b | 21.7x | 31.2x | 2.2x |
| Mon, 24 Jun 2024 | NT$87.8b | NT$38.9b | NT$2.8b | 24.1x | 31.6x | 2.3x |
| Wed, 22 May 2024 | NT$86.5b | NT$39.0b | NT$2.8b | 20.6x | 31.3x | 2.2x |
| Fri, 19 Apr 2024 | NT$86.4b | NT$38.9b | NT$2.8b | 21.3x | 30.5x | 2.2x |
| Sun, 17 Mar 2024 | NT$87.8b | NT$38.8b | NT$3.0b | 22.9x | 29.7x | 2.3x |
| Tue, 13 Feb 2024 | NT$87.5b | NT$37.9b | NT$2.8b | 23.4x | 31.3x | 2.3x |
| Thu, 11 Jan 2024 | NT$86.5b | NT$37.1b | NT$2.8b | 23.1x | 31.4x | 2.3x |
| Sat, 09 Dec 2023 | NT$83.8b | NT$37.1b | NT$2.8b | 24x | 30.4x | 2.3x |
| Mon, 06 Nov 2023 | NT$84.6b | NT$37.0b | NT$2.9b | 24.2x | 29.1x | 2.3x |
| Wed, 04 Oct 2023 | NT$90.6b | NT$37.0b | NT$2.9b | 25x | 31.1x | 2.4x |
| Fri, 01 Sep 2023 | NT$89.0b | NT$37.0b | NT$2.9b | 24.5x | 30.6x | 2.4x |
| Sun, 30 Jul 2023 | NT$93.7b | NT$37.4b | NT$3.0b | 23.5x | 31.5x | 2.5x |
| Tue, 27 Jun 2023 | NT$94.0b | NT$37.3b | NT$3.0b | 24.4x | 31.8x | 2.5x |
| Thu, 25 May 2023 | NT$94.0b | NT$37.0b | NT$3.1b | 22.9x | 30.5x | 2.5x |
| Sat, 22 Apr 2023 | NT$90.0b | NT$36.8b | NT$3.0b | 19.2x | 29.6x | 2.4x |
| Mon, 20 Mar 2023 | NT$85.7b | NT$36.4b | NT$3.3b | 18.6x | 26x | 2.4x |
| Wed, 15 Feb 2023 | NT$79.6b | NT$36.5b | NT$3.3b | 18x | 24.1x | 2.2x |
24.1x
Which industries have driven the changes within the Taiwanese Healthcare industry?
| TW Market | -1.02% | |
| Healthcare | -1.61% | |
| Healthcare Services | -2.01% | |
| Healthcare Services | -1.68% | |
| Healthcare Distributors | -2.07% | |
| Healthcare Facilities | -3.93% | |
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| 6615 Sofiva GenomicsLtd | NT$34.00 | 16.4% +NT$103.6m | -18.1% | PS1.9x | |
| 6879 TCI GENE | NT$38.00 | 5.6% +NT$52.9m | -26.9% | PE28.1x | |
| 6518 Concord Medical | NT$26.60 | 2.7% +NT$23.3m | 2.1% | PE16.2x | |
| 4139 Ma Kuang Healthcare Holding | NT$24.00 | 1.9% +NT$20.3m | -21.1% | PS1x | |
| 6744 Feng Chi Biotech | NT$17.50 | 6.4% +NT$16.2m | -11.4% | PE17.2x |